Vaccination of pneumococcal infection in patients with systemic lupus erythe matosus and antiphospholipid syndrome: experience of 6 years of use
Infections remain one of the main causes of morbidity and mortality in patients with immuno-inflammatory rheumatic diseases. Objective – to study the efficacy, immunogenicity and safety of the 23-valent polysaccharide pneumococcal vaccine (PPV-23) in patients with systemic lupus erythematosus (SLE)...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2023-06-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/3360 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|